{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:04:28Z","timestamp":1793945068126,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.healun.2024.11.033","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T12:05:32Z","timestamp":1733313932000},"page":"950-960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Basiliximab induction immunosuppression and lung transplant outcomes: Propensity analysis in a multicenter cohort"],"prefix":"10.1016","volume":"44","author":[{"given":"Jeeyon G.","family":"Rim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne S.","family":"Hellkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L.","family":"Neely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Belperio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Budev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0648-2509","authenticated-orcid":false,"given":"Lerin","family":"Eason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney W.","family":"Frankel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4547-8094","authenticated-orcid":false,"given":"Shaf","family":"Keshavjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7581-8619","authenticated-orcid":false,"given":"Jerry","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne G.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pali D.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie D.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Samuel Weigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.healun.2024.11.033_bib1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201910-1915OC","article-title":"Risk factors for acute rejection in the first year after lung transplant. A multicenter study","volume":"202","author":"Todd","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2024.11.033_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.864545","article-title":"Induction strategies in lung transplantation: alemtuzumab vs. basiliximab a single-center experience","volume":"13","author":"Furukawa","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.healun.2024.11.033_bib3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","article-title":"Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group","volume":"67","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"issue":"9086","key":"10.1016\/j.healun.2024.11.033_bib4","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","article-title":"Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group","volume":"350","author":"Nashan","year":"1997","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.healun.2024.11.033_bib5","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00007890-200110150-00014","article-title":"A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients","volume":"72","author":"Ponticelli","year":"2001","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.healun.2024.11.033_bib6","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.healun.2004.09.010","article-title":"A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation","volume":"24","author":"Mehra","year":"2005","journal-title":"J Heart Lung Transpl"},{"issue":"2","key":"10.1016\/j.healun.2024.11.033_bib7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/jlts.2002.30302","article-title":"Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial","volume":"8","author":"Neuhaus","year":"2002","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.healun.2024.11.033_bib8","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.healun.2019.08.001","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: donor and recipient size match","volume":"38","author":"Chambers","year":"2019","journal-title":"J Heart Lung Transpl"},{"issue":"6","key":"10.1016\/j.healun.2024.11.033_bib9","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/ajt.15957","article-title":"Highlights from the clinical trials in organ transplantation (CTOT)-20 and CTOT-22 Consortium studies in lung transplant","volume":"20","author":"Snyder","year":"2020","journal-title":"Am J Transpl"},{"issue":"1","key":"10.1016\/j.healun.2024.11.033_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ajt.2023.08.014","article-title":"Center variability in the prognostic value of a cumulative acute cellular rejection \"A-score\" for long-term lung transplant outcomes","volume":"24","author":"Belousova","year":"2024","journal-title":"Am J Transpl"},{"issue":"12","key":"10.1016\/j.healun.2024.11.033_bib11","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transpl"},{"issue":"12","key":"10.1016\/j.healun.2024.11.033_bib12","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1111\/ajt.17183","article-title":"Prognostic implications of and clinical risk factors for acute lung injury and organizing pneumonia after lung transplantation: data from a multicenter prospective cohort study","volume":"22","author":"Pavlisko","year":"2022","journal-title":"Am J Transpl"},{"issue":"5","key":"10.1016\/j.healun.2024.11.033_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment-a consensus report from the Pulmonary Council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transpl"},{"issue":"25","key":"10.1016\/j.healun.2024.11.033_bib14","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.healun.2024.11.033_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S2213-2600(23)00293-X","article-title":"Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial","volume":"12","author":"Dellgren","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.healun.2024.11.033_bib16","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.healun.2024.11.033_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/691464","article-title":"Improving causal inference: recommendations for covariate selection and balance in propensity score methods","volume":"8","author":"Kainz","year":"2017","journal-title":"J Soc Soc Work Res"},{"issue":"11","key":"10.1016\/j.healun.2024.11.033_bib18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/oxfordjournals.aje.a116813","article-title":"Simulation study of confounder-selection strategies","volume":"138","author":"Maldonado","year":"1993","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.healun.2024.11.033_bib19","first-page":"250","article-title":"Addressing extreme propensity scores via the overlap weights","volume":"188","author":"Li","year":"2019","journal-title":"Am J Epidemiol"},{"issue":"521","key":"10.1016\/j.healun.2024.11.033_bib20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/01621459.2016.1260466","article-title":"Balancing covariates via propensity score weighting","volume":"113","author":"Li","year":"2018","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"10.1016\/j.healun.2024.11.033_bib21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.athoracsur.2021.03.092","article-title":"The impact of center volume on outcomes in lung transplantation","volume":"113","author":"Yang","year":"2022","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"10.1016\/j.healun.2024.11.033_bib22","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1513\/AnnalsATS.201601-017OC","article-title":"Effect of transplant center volume on cost and readmissions in medicare lung transplant recipients","volume":"13","author":"Mooney","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.healun.2024.11.033_bib23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/TP.0b013e3181ceecf7","article-title":"Temporal trends in lung transplant center volume and outcomes in the United States","volume":"89","author":"Scarborough","year":"2010","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.healun.2024.11.033_bib24","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jtcvs.2012.08.047","article-title":"The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation","volume":"144","author":"Kilic","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.healun.2024.11.033_bib25","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1164\/rccm.201509-1857OC","article-title":"De Novo DQ donor-specific antibodies are associated with chronic lung allograft dysfunction after lung transplantation","volume":"194","author":"Tikkanen","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.healun.2024.11.033_bib26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1378\/chest.12-0587","article-title":"Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients","volume":"144","author":"Snyder","year":"2013","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.healun.2024.11.033_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1053-2498(02)00477-1","article-title":"Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management","volume":"22","author":"Singh","year":"2003","journal-title":"J Heart Lung Transpl"},{"issue":"12","key":"10.1016\/j.healun.2024.11.033_bib28","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1164\/rccm.200911-1786OC","article-title":"Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation","volume":"181","author":"Snyder","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.healun.2024.11.033_bib29","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1016\/j.transproceed.2005.09.192","article-title":"Comparative study of basiliximab treatment in lung transplantation","volume":"37","author":"Borro","year":"2005","journal-title":"Transpl Proc"},{"issue":"8","key":"10.1016\/j.healun.2024.11.033_bib30","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1111\/ajt.13739","article-title":"The impact of alemtuzumab and basiliximab induction on patient survival and time to bronchiolitis obliterans syndrome in double lung transplantation recipients","volume":"16","author":"Furuya","year":"2016","journal-title":"Am J Transpl"},{"issue":"5","key":"10.1016\/j.healun.2024.11.033_bib31","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3109\/15412555.2015.1127340","article-title":"Induction therapy for lung transplantation in COPD: analysis of the UNOS registry","volume":"13","author":"Duffy","year":"2016","journal-title":"COPD"},{"issue":"2","key":"10.1016\/j.healun.2024.11.033_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3349\/ymj.2021.62.2.164","article-title":"Basiliximab induction with delayed calcineurin inhibitors for high-risk lung transplant candidates","volume":"62","author":"Kim","year":"2021","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.healun.2024.11.033_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14782","article-title":"Induction therapy in lung transplantation: a contemporary analysis of trends and outcomes","author":"Shagabayeva","year":"2022","journal-title":"Clin Transpl"},{"issue":"5","key":"10.1016\/j.healun.2024.11.033_bib34","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1399-0012.2008.00831.x","article-title":"The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry","volume":"22","author":"Hachem","year":"2008","journal-title":"Clin Transpl"},{"issue":"4","key":"10.1016\/j.healun.2024.11.033_bib35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/ctr.12339","article-title":"To induce or not to induce: a 21st century evaluation of lung transplant immunosuppression's effect on survival","volume":"28","author":"Whitson","year":"2014","journal-title":"Clin Transpl"},{"key":"10.1016\/j.healun.2024.11.033_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101778","article-title":"Basiliximab is associated with a lower incidence of De novo donor-specific HLA antibodies in kidney transplant recipients: A single-center experience","volume":"77","author":"Jarmi","year":"2023","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.healun.2024.11.033_bib37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fimmu.2018.00275","article-title":"CD4+ T cell help is mandatory for naive and memory donor-specific antibody responses: impact of therapeutic immunosuppression","volume":"9","author":"Chen","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.healun.2024.11.033_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-5223(97)70144-2","article-title":"Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation","volume":"114","author":"Kroshus","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.healun.2024.11.033_bib39","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1164\/ajrccm.159.3.9607099","article-title":"Analysis of risk factors for the development of bronchiolitis obliterans syndrome","volume":"159","author":"Husain","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.healun.2024.11.033_bib40","first-page":"1200","article-title":"Risk factors for the development of obliterative bronchiolitis after lung transplantation","volume":"15","author":"Girgis","year":"1996","journal-title":"J Heart Lung Transpl"},{"issue":"2","key":"10.1016\/j.healun.2024.11.033_bib41","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1164\/ajrccm.163.2.2005031","article-title":"Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation","volume":"163","author":"Schulman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.healun.2024.11.033_bib42","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/TP.0b013e318286e076","article-title":"Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?","volume":"95","author":"Verleden","year":"2013","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.healun.2024.11.033_bib43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.healun.2003.10.024","article-title":"Significance of a solitary perivascular mononuclear infiltrate in lung allograft recipients with mild acute cellular rejection","volume":"24","author":"Kim","year":"2005","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"10.1016\/j.healun.2024.11.033_bib44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/ajt.15561","article-title":"The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation","volume":"20","author":"Levy","year":"2020","journal-title":"Am J Transpl"},{"issue":"4","key":"10.1016\/j.healun.2024.11.033_bib45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1164\/rccm.201206-1025OC","article-title":"Association of large-airway lymphocytic bronchitis with bronchiolitis obliterans syndrome","volume":"187","author":"Greenland","year":"2013","journal-title":"Am J Respir Crit Care Med"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249824020035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249824020035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T15:15:15Z","timestamp":1762355715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249824020035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1053249824020035"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2024.11.033","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Basiliximab induction immunosuppression and lung transplant outcomes: Propensity analysis in a multicenter cohort","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2024.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Heart and Lung Transplantation. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}